The move could allow EU governments to secure vaccines from companies that are not negotiating with Brussels, such as U.S. firms Merck, Inovio and Novavax. They are all in talks with the WHO scheme, dubbed COVAX, but have so far not been reported to be involved in negotiations with the EU Commission.
Nachrichten direkt von der Quelle. Im Kontext sehen. News Agency of Radio Utopie. News directly from the source. There is context in life. Deutsch, English. 24 h. – Democracy First!